{Reference Type}: Journal Article
{Title}: Penicillium chrysogenum: Beyond the penicillin.
{Author}: Barreiro C;Albillos SM;García-Estrada C;
{Journal}: Adv Appl Microbiol
{Volume}: 127
{Issue}: 0
{Year}: 2024
{Factor}: 5.515
{DOI}: 10.1016/bs.aambs.2024.02.006
{Abstract}: Almost one century after the Sir Alexander Fleming's fortuitous discovery of penicillin and the identification of the fungal producer as Penicillium notatum, later Penicillium chrysogenum (currently reidentified as Penicillium rubens), the molecular mechanisms behind the massive production of penicillin titers by industrial strains could be considered almost fully characterized. However, this filamentous fungus is not only circumscribed to penicillin, and instead, it seems to be full of surprises, thereby producing important metabolites and providing expanded biotechnological applications. This review, in addition to summarizing the classical role of P. chrysogenum as penicillin producer, highlights its ability to generate an array of additional bioactive secondary metabolites and enzymes, together with the use of this microorganism in relevant biotechnological processes, such as bioremediation, biocontrol, production of bioactive nanoparticles and compounds with pharmaceutical interest, revalorization of agricultural and food-derived wastes or the enhancement of food industrial processes and the agricultural production.